EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.31.10

Gates Foundation Criticised Again for Monopolising Research

Posted in Bill Gates, Finance, Patents at 3:30 am by Dr. Roy Schestowitz

“The chief of malaria for the World Health Organization has complained that the growing dominance of malaria research by the Bill and Melinda Gates Foundation risks stifling a diversity of views among scientists and wiping out the world health agency’s policy-making function.

New York Times, 2008

Summary: Research diversity is being stifled by the Gates Foundation and Gates-funded ‘studies’ spread misconceptions to defend the foundation’s own agenda

THE Gates Foundation is relevant to this Web site because of the role it plays in promoting Microsoft at the expense of software freedom. Today’s post is more closely related to patents than software and we kindly ask readers to revisit some background in order to understand how the Gates Foundation promotes patents on solutions that save people’s lives. It’s an issue of scarcity where any scarcity means loss of life (patents being the expensive component, not manufacturing).

Thanks to PR efforts from the Gates Foundation (which contracts outside agencies to manage its PR), several high-profile publications continue to promote Gates as a saviour of lives, but the truth (or reality) is a little more complicated than that. Some honourable people do talk about it, but the amount of PR typically marginalises them (by sheer volume).

“Big Pharma gets on board with Gates Foundation,” says this new article which points out:

Although most observers of the Gates Foundation highlight the organization’s influence over grantees, it is clear that the world’s largest philanthropy is exerting a strong influence over the pharmaceutical industry.

As we have shown before, the Gates Foundation is a shareholder and a benefactor in this industry. There actually is a conflict of interests. The Gates Foundation is monopolising research while investing (in the shareholder sense) in the companies that benefit from it. As the Indian press put it some days ago:

Should it be just one big idea, the way Bill and Melinda Gates foundation tackles malaria? (Not even a nano comparison in terms of funding).

The investments are selective and they sometimes come with strings attached. This puts a lot of pressure on researchers to comply with the plan of the Gates Foundation and not anything else. Is this the free thinking that research requires? Does that permit diversity of opinions and breadth of exploration?

Here is another new article:

Although the British drug giant known as GSK was heralded by leading health organizations, the driving force behind the disclosure was the Bill & Melinda Gates Foundation.

For those who do not know or remember, the Head of Global Health for the Gates Foundation is from GlaxoSmithKline where he was caught abusing outside researchers who did not agree with him. Charles Grassley was there in the Senate investigating such inexcusable abuse. GlaxoSmithKline is not the only company which is very much inside the Gates Foundation and we gave more examples before (even Monsanto staff is inside the Gates Foundation).

Anyway, this man is called Tachi Yamada and here he is speaking to the press some days ago.

“Grand Challenges Explorations continues to generate unique and creative ways to tackle global health issues,” said Tachi Yamada, president of the Gates Foundation’s Global Health Programme.

To complete his sentence, they strive to generate unique and creative ways to tackle global health issues by paying big pharmaceutical companies after lobbying governments to allocate funds. That does not mean that the Gates Foundation won’t pay anything; it does pay generously, but it also uses its brand power to further boost investment in companies which it has investments in, using taxpayers' money for the most part. Look who is managing some of these funds:

Arabella Philanthropic Investment Advisors, a philanthropy services firm, is working with ultra-wealthy families’ foundations that are looking to make a philanthropic impact with fewer resources. The firm has done work for The Bill and Melinda Gates Foundation, The Mead Family Foundation and for corporations like Caterpillar and Hyatt.

One might say that taxpayers choose to support Gates’ vision, but not everyone agrees. Gates has just produced a self-serving ‘study’ [1, 2] which is being called “absolute nonsense” by someone who is simply not agreeing with the results of such Gates Foundation-funded research. There is an article about it:

FAIR CEO Blasts Kaiser Foundation & Public Agenda HIV/AIDS Study Results as ‘Absolute Nonsense’

The President and CEO of the FAIR Foundation, Dr. Richard Darling, DDS, is publicly denouncing research studies by the Kaiser Family Foundation and Public Agenda which conclude that Americans want more money spent on HIV/AIDS.

[...]

FAIR points out that in addition to the exorbitant federal funding, The Bill & Melinda Gates Foundation has spent approximately $7 billion on global HIV, TB & malaria efforts and billions of additional dollars have been spent on behalf of HIV patients by the collective efforts of pharmaceutical companies, Hollywood AIDS activists and non-profit organizations such as amfAR (American Federation for AIDS Research).

Let’s not forget the Lancet study from Gates — a ‘study’ which was quite widely disputed [1, 2, 3, 4] but is still appearing in the press.

A new study published in the Lancet and funded by the Gates Foundation, looks at rates of decline, and accelerations and decelerations in rates of decline, in mortality in children younger than 5 years for 187 countries from 1970 to 2009.

There is a quiet fight going on between those who advance the Gates agenda and those who understand that his monopolisation of research (and incestuous relationship with particular companies) is a dangerous one for refinement of drugs. It’s simply irresponsible not to report on these issues, however inconvenient it might be to bring them up.

“Gates has created a huge blood-buying operation that only cares about money, not about people.”

AIDS organisation manager, December 2009 (New York Times)

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

2 Comments

  1. Needs Sunlight said,

    May 31, 2010 at 8:20 am

    Gravatar

    It’s not research, don’t call it that. It’s marketing. Please call it correctly. New Speak can be ignored.

    Dr. Roy Schestowitz Reply:

    To an outside observer it would be “weasel words” (calling research “marketing”). Let’s not preach only to the choir and instead make analysis more widely accessible.

    It is possible to show that research is “marketing” without actually stating this directly.

What Else is New


  1. Links 20/6/2018: Qt 5.11.1, Oracle Solaris 11.3 SRU 33, HHVM 3.27.0, Microsoft Helping ICE

    Links for the day



  2. Patent Extremists Are Unable to Find Federal Circuit Cases That Help Them Mislead on Alice

    Patent extremists prefer talking about Mayo but not Alice when it comes to 35 U.S.C. § 101; Broadcom is meanwhile going on a 'fishing expedition', looking to profit from patents by calling for embargo through the ITC



  3. What Use Are 10 Million Patents That Are of Low Quality in a Patent Office Controlled by the Patent 'Industry'?

    The patent maximalists are celebrating overgranting; the USPTO, failing to heed the warning from patent courts, continues issuing far too many patents and a new paper from Mark Lemley and Robin Feldman offers a dose of sobering reality



  4. The Eastern District of Texas is Where Asian Companies/Patents/Trolls Still Go After TC Heartland

    Proxies of Longhorn IP and KAIST (Katana Silicon Technologies LLC and KAIST IP US LLC, respectively) roam Texas in pursuit of money of out nothing but patents and aggressive litigation; there's also a Microsoft connection



  5. EPO Insiders Correct the Record of Benoît Battistelli’s Tyranny and Abuse of Law: “Legal Harassment and Retaliation”

    Battistelli’s record, as per EPO-FLIER 37, is a lot worse than the Office cares to tell stakeholders, who are already complaining about decline in patent quality



  6. Articles About a Unitary Patent System Are Lies and Marketing From Law Firms With 'Lawsuits Lust'

    Team UPC has grown louder with its lobbying efforts this past week; the same lies are being repeated without much of a challenge and press ownership plays a role in that



  7. The Decline in Patent Quality at the EPO Causes Frivolous Lawsuits That Only Lawyers Profit From

    The European Patent Office (EPO) will continue granting low-quality European Patents under the leadership of the Battistelli-'nominated' Frenchman, António Campinos; this is bad news for science and technology as that quite likely means a lot more lawsuits without merit (which only lawyers profit from)



  8. What Battistelli's Workers Think of His Latest EPO Propaganda

    "Modernising the EPO" is what Battistelli calls a plethora of human rights abuses and corruption



  9. Links 19/6/2018: Total War: WARHAMMER II Confirmed for GNU/Linux, DragonFlyBSD 5.2.2 Released

    Links for the day



  10. More Media Reports About Decline in Quality of European Patents (Granted by the EPO)

    What the media is saying about the letter from Grünecker, Hoffmann Eitle, Maiwald and Vossius & Partner whilst EPO communications shift attention to shallow puff pieces about how wonderful Benoît Battistelli is



  11. Beware Team UPC's Biggest Two Lies About the Unitary Patent (UPC)

    Claims that a Unified Patent Court (UPC) will commence next year are nothing but a fantasy of the Liar in Chief, Benoît Battistelli, who keeps telling lies to French media (some of which he passes EPO money to, just like he passes EPO money to his other employer)



  12. Diversity at the EPO

    Two decades of EPO with 16-17 years under the control of French Presidents (and nowadays predominantly French management in general with Inventor Award held in France almost half the time) is "diversity at the EPO"



  13. Orrin Hatch, Sponsored the Most by the Pharmaceutical Industry, Tries to Make Its Patents Immune From Scrutiny (PTAB)

    Orrin Hatch is the latest example of laws being up for sale, i.e. companies can 'buy' politicians to act as their 'couriers' and pass laws for them, including laws pertaining to patents



  14. Links 17/6/2018: Linux 4.18 RC1 and Deepin 15.6 Released

    Links for the day



  15. To Keep the Patent System Alive and Going Practitioners Will Have to Accept Compromises on Scope Being Narrowed

    35 U.S.C. § 101 still squashes a lot of software patents, reducing confidence in US patents; the only way to correct this is to reduce patent filings and file fewer lawsuits, judging their merit in advance based on precedents from higher courts



  16. The Affairs of the USPTO Have Turned Into Somewhat of a Battle Against the Courts, Which Are Simply Applying the Law to Invalidate US Patents

    The struggle between law, public interest, and the Cult of Patents (which only ever celebrates more patents and lawsuits) as observed in the midst of recent events in the United States



  17. Patent Marketing Disguised as Patent 'Advice'

    The meta-industry which profits from patents and lawsuits claims that it's guiding us and pursuing innovation, but in reality its sole goal is enriching itself, even if that means holding science back



  18. Microsoft is Still 'Cybermobbing' Its Competition Using Patent Trolls Such as Finjan

    In the "cybersecurity" space, a sub-domain where many software patents have been granted by the US patent office, the patent extortion by Microsoft-connected trolls (and Microsoft's 'protection' racket) seems to carry on; but Microsoft continues to insist that it has changed its ways



  19. Links 16/6/2018: LiMux Story, Okta Openwashing and More

    Links for the day



  20. The EPO's Response to the Open Letter About Decline in Patent Quality as the Latest Example of Arrogance and Resistance to Facts, Truth

    Sidestepping the existential crisis of the EPO (running out of work and issuing many questionable patents with expectation of impending layoffs), the PR people at the Office choose a facts-denying, face-saving 'damage control' strategy while staff speaks out, wholeheartedly agreeing with concerned stakeholders



  21. In the United States the Patent Trial and Appeal Board, Which Assures Patent Quality, is Still Being Smeared by Law Firms That Profit From Patent Maximalism, Lawsuits

    Auditory roles which help ascertain high quality of patents (or invalidate low-quality patents, at least those pointed out by petitions) are being smeared, demonised as "death squads" and worked around using dirty tricks that are widely described as "scams"



  22. The 'Artificial Intelligence' (AI) Hype, Propped Up by Events of the European Patent Office (EPO), is Infectious and It Threatens Patent Quality Worldwide

    Having spread surrogate terms like “4IR” (somewhat of a 'mask' for software patents, by the EPO's own admission in the Gazette), the EPO continues with several more terms like “ICT” and now we’re grappling with terms like “AI”, which the media endlessly perpetuates these days (in relation to patents it de facto means little more than "clever algorithms")



  23. Links 15/6/2018: HP Chromebook X2 With GNU/Linux Software, Apple Admits and Closes a Back Door ('Loophole')

    Links for the day



  24. The '4iP Council' is a Megaphone of Team UPC and Team Battistelli at the EPO

    The EPO keeps demonstrating lack of interest in genuine patent quality (it uses buzzwords to compensate for deviation from the EPC and replaces humans with shoddy translators); it is being aided by law firms which work for patent trolls and think tanks that propel their interests



  25. Grünecker, Hoffmann Eitle, Maiwald and Vossius & Partner Find the Courage to Express Concerns About Battistelli's Ugly Legacy and Low Patent Quality

    The astounding levels of abuse at the EPO have caused some of the EPO's biggest stakeholders to speak out and lash out, condemning the Office for mismanagement amongst other things



  26. IAM Concludes Its Latest Anti-§ 101 Think Tank, Featuring Crooked Benoît Battistelli

    The attack on 35 U.S.C. § 101, which invalidates most if not all software patents, as seen through the lens of a Battistelli- and Iancu-led lobbying event (set up by IAM)



  27. Google Gets Told Off -- Even by the Typically Supportive EFF and TechDirt -- Over Patenting of Software

    The EFF's Daniel Nazer, as well as TechDirt's founder Mike Masnick, won't tolerate Google's misuse of Jarek Duda's work; the USPTO should generally reject all applications for software patents -- something which a former Commissioner for Patents at the USPTO seems to be accepting now (that such patents have no potency after Alice)



  28. From the Eastern District of Texas to Delaware, US Patent Litigation is (Overall) Still Declining

    Patent disputes/conflicts are increasingly being settled outside the courts and patents that aren't really potent/eligible are being eliminated or never brought forth at all



  29. Links 13/6/2018: Cockpit 170, Plasma 5.13, Krita 4.0.4

    Links for the day



  30. When the USPTO Grants Patents in Defiance of 35 U.S.C. § 101 the Courts Will Eventually Squash These Anyway

    Software/abstract patents, as per § 101 (Section 101) which relates to Alice Corp v CLS Bank at the US Supreme Court, are not valid in the United States, albeit one typically has to pay a fortune for a court battle to show it because the patent office (USPTO) is still far too lenient and careless


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts